Results 81 to 90 of about 186,455 (191)

Low Molecular Weight Heparin Induced Skin Necrosis without Platelet Fall Revealing Immunoallergic Heparin Induced Thrombocytopenia

Case Reports in Hematology, 2013
Low molecular weight heparins (LMWH) are commonly used in the ICU setting for thromboprophylaxis as well as curative decoagulation as required during renal replacement therapy (RRT).
Thomas Godet, Sébastien Perbet, Aurélien Lebreton, Guillaume Gayraud, Sophie Cayot, Aymeric Tremblay, Aurélie Ravinet, Sébastien Christophe, Renaud Guérin, Julien Pascal, Matthieu Jabaudon, Amr Hassan, Anne-Françoise Sapin, Jean-Etienne Bazin, Jean-Michel Constantin   +14 more
doaj   +1 more source

COVID-19, Low-Molecular-Weight Heparin, and Hemodialysis

Kidney & Blood Pressure Research, 2020
Alessandra F. Perna, Giovanna Capolongo, Francesco Trepiccione, Mariadelina Simeoni, Miriam Zacchia, Diego Ingrosso   +5 more
doaj   +1 more source

The PREVAIL trial and low-molecular-weight heparin for prevention of venous thromboembolism [PDF]

, 2008
Muir, K.W.
core   +1 more source

Syncope in Elderly People: A Threatening Presentation of Pulmonary Embolism: A Case Report [PDF]

, 2015
age. Its prognosis is largely unpredictable, pending the origin of the sudden loss of consciousness. We report a case of an old woman affected by severe chronic heart failure, who died soon after the development of an episode of syncope, which was ...
Bilora, Franca, Lucia, Sarolo, Pomerri, Fabio, Prandoni, Paolo   +3 more
core  

Update on the clinical use of the low-molecular-weight heparin, parnaparin

Vascular Health and Risk Management, 2009
Giuseppe Camporese1, Enrico Bernardi2, Franco Noventa31Unit of Angiology and 3Department of Clinical and Experimental Medicine, Clinical Epidemiology Group, University Hospital of Padua, Italy; 2Department of Emergency and Accident Medicine, Hospital of ...
Giuseppe Camporese, Enrico Bernardi, Franco Noventa   +2 more
doaj  

What's the best way to manage upper extremity venous thrombosis? [PDF]

, 2010
Standard management is best: Start with unfractionated heparin or low-molecular-weight heparin and follow with long-term therapy with a vitamin K antagonist (strength of recommendation [SOR]: C, expert consensus and case reports).
Goodemote, Patricia, Jamieson, Barbara, Rabens, Clayton   +2 more
core  

Heparin therapy in sepsis and sepsis-associated disseminated intravascular coagulation: a systematic review and meta-analysis

Thrombosis Journal
Background Sepsis is a life-threatening condition that affects 49 million people annually. Managing sepsis-associated coagulopathy poses a significant challenge due to its high mortality rates in intensive care.
Takaaki Totoki, Hiroyuki Koami, Yuto Makino, Takeshi Wada, Takashi Ito, Kazuma Yamakawa, Toshiaki Iba   +6 more
doaj   +1 more source

Association between skeletal muscle mass and serum concentrations of lipoprotein lipase, GPIHBP1, and hepatic triglyceride lipase in young Japanese men [PDF]

, 2019
学位記番号 ...
Matsumoto, Ryutaro, マツモト, リュウタロウ, 松本, 隆太郎   +2 more
core  

The methods of assessment of quality and safety of medicaments on the basis of low molecular weight heparins

Сеченовский вестник, 2011
To consider the methods for assessing quality and safety of drugs on the basis of low molecular weight heparin.
E. A. Arianova, M. N. Bogachuk, O. I. Perederyaev   +2 more
doaj  

Low-Molecular-Weight Heparin for Adult ICU Patients Who Require Thromboprophylaxis: Protocol for the INCEPT-Thromboprophylaxis Platform Trial Domain. [PDF]

Acta Anaesthesiol Scand
Eck R, Granholm A, Tøgern A, Jensen AKG, Jonmarker S, Sjövall F, Meijer K, Cronhjort M, Møller MH, Perner A, Keus F.   +10 more
europepmc   +1 more source